GE Medical Systems of Milwaukee and Agfa of Ridgefield Park, NJ, have reconciled their dispute over former Agfa PACS executive Vishal Wanchoo, who was hired by GE in November. GE and Agfa parent Bayer announced Dec. 17 that they have resolved the civil
GE Medical Systems of Milwaukee and Agfa of Ridgefield Park, NJ, have reconciled their dispute over former Agfa PACS executive Vishal Wanchoo, who was hired by GE in November. GE and Agfa parent Bayer announced Dec. 17 that they have resolved the civil lawsuit that Bayer filed seeking to prevent Wanchoo from disclosing Agfa trade secrets.
GE brought Wanchoo in to lead its Integrated Imaging Solutions PACS unit, replacing Anthony Lombardo, who has been named general manager of IIS Americas sales. Wanchoo previously had been vice president of marketing at Agfa and was attributed with being one of the players who helped build Agfa into a PACS powerhouse.
GE may have received more than it bargained for in hiring Wanchoo, however. Bayer's lawsuit sought a temporary restraining order to prevent Wanchoo from using Agfa trade secrets and confidential customer information. The legal imbroglio was the talk of the exhibit floor at this month's Radiological Society of North America meeting.
Both companies apparently decided it was better to settle than fight. The terms of the agreement were not disclosed, but Agfa executive vice president Erhard Rittinghaus said the company was satisfied that the deal would protect its business interests.
GE and Agfa will continue to cooperate in ensuring product compatibility in medical imaging archiving systems. The settlement did not include a monetary payment.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.